Well Referenced

Tag: lipoprotein(a)

Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes

This review article discusses the clinical significance of lipoprotein(a) [Lp(a)] as an independent risk factor for cardiovascular diseases, including coronary artery disease and calcific aortic valve disease. It highlights that Lp(a) levels are genetically determined and remain constant throughout life. The article emphasizes the importance of measuring Lp(a) levels for

Read More »
June 26, 2025 No Comments

Lipoprotein(a) and Cardiovascular Disease: A Missing Link for Premature Atherosclerotic Heart Disease and/or Residual Risk

This comprehensive review highlights lipoprotein(a) [Lp(a)] as a genetically determined, independent risk factor for various cardiovascular diseases, including coronary artery disease, aortic valve stenosis, ischemic stroke, heart failure, and peripheral arterial disease. Elevated Lp(a) levels (≥50 mg/dL or ≥100 nmol/L) are prevalent in approximately 20% of the population and contribute

Read More »
June 26, 2025 No Comments

Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study

This observational study followed 4,510 older adults over 9 years and found that elevated levels of specific biomarkers related to inflammation and hemostasis, such as IL-6, CRP, D-dimer, homocysteine, WBC count, factor VIII, and lipoprotein(a), were significantly associated with increased cardiovascular risk. The study also noted gender differences in biomarker

Read More »
June 26, 2025 No Comments